Rein Therapeutics Inc (RNTX) stock news · $80.6M cap
Rein Therapeutics Inc (RNTX) is a biotechnology company listed on NASDAQ.
This RNTX news page leads with what Rein Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for RNTX yet. We will not pad this page with generic market recap.
Latest reported RNTX revenue for 2025-12-31 was $0. Net income was -$49.9M. RNTX currently screens at market cap $80.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the RNTX stock page; for the tape open the quote page.
RNTX stock news FAQ
What is RNTX's latest net income?
Latest cached Rein Therapeutics Inc (RNTX) net income was -$49.9M. Statements: https://lician.com/financials/rntx
What is RNTX's market cap?
Rein Therapeutics Inc (RNTX) market cap is $80.6M on the latest cached fundamentals snapshot.
What kind of company is RNTX?
Rein Therapeutics Inc (RNTX) is a biotechnology company listed on NASDAQ.
Where is RNTX stock news listed?
Cached stock news for Rein Therapeutics Inc (RNTX) is listed at https://lician.com/news/rntx. Filings: https://lician.com/sec/rntx
Not investment advice.